406-420 of 894
Optimizing HCC Screening: Strategies to Overcome Common Barriers
Project Oncology®Optimizing HCC Screening: Strategies to Overcome Common Barriers
Hannah Lee, MD
The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Project Oncology®The Potential Impact of RCC Molecular Subtypes on Treatment Outcomes
Jody Takemoto, PhD, MEd
David Braun, MD, PhD
Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Project Oncology®Delivering Guideline-Based Hepatocellular Carcinoma Care with an Interactive Tool
Jody Takemoto, PhD, MEd
Robert Wong, MD
An Overview of the Fundamentals of PET-CT Imaging
Project Oncology®An Overview of the Fundamentals of PET-CT Imaging
Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Project Oncology®Emerging Frontiers: CAR T-Cell Therapy for Solid Tumors in Thyroid Cancer
Matt Birnholz, MD
Saad Kenderian M.B, Ch.B
- advertisement
Current Updates in Brain Imaging and Neurodegenerative Diseases
Project Oncology®Current Updates in Brain Imaging and Neurodegenerative Diseases
Phillip H. Kuo, MD, PhD
Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection
Project Oncology®Dual Challenges: Managing Hepatocellular Carcinoma with Hepatitis B Co-Infection
Jody Takemoto, PhD, MEd
Robert Wong, MD
Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
Project Oncology®Uncovering Barriers to HCC Surveillance in Patients with Cirrhosis
Jody Takemoto, PhD, MEd
Robert Wong, MD
Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Project Oncology®Salivary Toxicity from PSMA-Targeted Radiopharmaceuticals in mCRPC
Geoffrey B. Johnson, M.D., Ph.D.
A Look at the Utility of PSMA PET Scans in Prostate Cancer
Project Oncology®A Look at the Utility of PSMA PET Scans in Prostate Cancer
Jennifer Caudle, DO, FACOFP
Geoffrey B. Johnson, M.D., Ph.D.
Diving into New Directions of Radiopharmaceuticals
Project Oncology®Diving into New Directions of Radiopharmaceuticals
Brianna Cagle
- advertisement
The Evolving AI Landscape in Nuclear Medicine
Project Oncology®The Evolving AI Landscape in Nuclear Medicine
Joyita Dutta
AI in Nuclear Medicine: Improvements in the Field
Project Oncology®AI in Nuclear Medicine: Improvements in the Field
Chi Liu, PhD
Decoding Risk: Genetic Testing in High-Risk Colon Cancer Patients
GI InsightsDecoding Risk: Genetic Testing in High-Risk Colon Cancer Patients
Jody Takemoto, PhD, MEd
Bryson Katona, MD, PhD
